Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

ClinicalTrials.gov ID: NCT06911424

Public ClinicalTrials.gov record NCT06911424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Multi-Center, Placebo-Controlled, Masked Study to Evaluate the Clinical Efficacy and Safety of Fusidic Acid 1% Viscous Topical Antibiotic Eye Drops for the Treatment of Suspected Bacterial Conjunctivitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctivitis and to further establish the safety profile of fusidic acid 1% for topical ocular administration.

Study identification

NCT ID
NCT06911424
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Baxis Pharmaceuticals, Inc.
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2025
Primary completion
Mar 15, 2026
Completion
Mar 22, 2026
Last update posted
Mar 16, 2026

2025 – 2026

United States locations

U.S. sites
38
U.S. states
17
U.S. cities
35
Facility City State ZIP Site status
Baxis Site 04 Little Rock Arkansas 72205 Recruiting
Baxis Site 24 Huntington Beach California 92647 Withdrawn
Baxis Site 19 La Jolla California 92037 Recruiting
Baxis Site 39 Long Beach California 90813 Recruiting
Baxis Site 31 Los Angeles California 90020 Recruiting
Baxis Site 38 Los Angeles California 90048 Recruiting
Baxis Site 20 Sherman Oaks California 91423 Terminated
Baxis Site 34 Delray Beach Florida 33484 Recruiting
Baxis Site 22 Doral Florida 33172 Terminated
Baxis Site 11 Lake Worth Florida 33460 Recruiting
Baxis Site 37 Largo Florida 33773 Recruiting
Baxis Site 27 Lutz Florida 33549 Recruiting
Baxis Site 01 Miami Florida 33155 Recruiting
Baxis Site 03 Miami Florida 33176 Terminated
Baxis Site 13 Miami Beach Florida 33140 Terminated
Baxis Site 28 Miami Lakes Florida 33014 Recruiting
Baxis Site 29 Palm Springs Florida 33461 Recruiting
Baxis Site 10 Tampa Florida 33613 Recruiting
Baxis Site 35 Union City Georgia 30291 Recruiting
Baxis Site 15 Idaho Falls Idaho 83404 Terminated
Baxis Site 06 Orland Park Illinois 60462 Recruiting
Baxis Site 26 Columbia Maryland 21045 Withdrawn
Baxis Site 21 North Las Vegas Nevada 89030 Terminated
Baxis Site 23 Babylon New York 11702 Withdrawn
Baxis Site 05 Mount Airy North Carolina 27030 Terminated
Baxis Site 25 Tulsa Oklahoma 74133 Withdrawn
Baxis Site 30 Gresham Oregon 97030 Recruiting
Baxis Site 09 Pittsburgh Pennsylvania 15227 Withdrawn
Baxis Site 12 Charleston South Carolina 29414 Recruiting
Baxis Site 33 Greenville South Carolina 29607 Recruiting
Baxis Site 08 Edinburg Texas 78539 Recruiting
Baxis Site 02 Humble Texas 77338 Terminated
Baxis Site 14 Kingwood Texas 77345 Terminated
Baxis Site 36 Mission Texas 78572 Recruiting
Baxis Site 17 Layton Utah 84041 Terminated
Baxis Site 18 Layton Utah 84041 Terminated
Baxis Site 16 West Valley City Utah 84120 Withdrawn
Baxis Site 32 Charlottesville Virginia 22902 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06911424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06911424 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →